Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- Check7 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA sitewide NIH notice appears above the ClinicalTrials.gov page, linking to transition updates and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe 403 error page remains unchanged, with the footer revision updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedA 403 Forbidden error page is now displayed when attempting to view the study page, replacing the content with an access error. The page shows a Home button, indicating the page is currently unavailable.SummaryDifference18%

- Check70 days agoChange DetectedFooter now shows Revision: v3.6.6, replacing the previous v3.6.5. This represents a small page-version update rather than a change to substantive content.SummaryDifference0.0%

Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.